News

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...
The weight-loss drug Ozempic is linked to dry mouth bad breath and other oral issues Here’s what the expert says about ...
It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...
Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...
We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
Patients regain weight after stopping weight loss drugs, long-term success may depend on lifestyle and drug choice.
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...
While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...
Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...
A new report from The Center for Medicine in the Public Interest (CMPI) warns that regulators are failing to stop the illegal ...
Everyone aspires to live a healthy life. The catch is that health is a moving target. It’s a challenge that changes as people ...